$2.4 Billion is the total value of Avoro Capital Advisors LLC's 33 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 22.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRTX | Sell | MIRATI THERAPEUTICS INC | $292,163,000 | -26.6% | 3,750,000 | -2.9% | 12.19% | -11.4% |
| IMMU | IMMUNOMEDICS INC | $278,460,000 | -4.4% | 21,000,000 | 0.0% | 11.62% | +15.4% | |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $192,939,000 | -26.8% | 10,601,039 | -1.4% | 8.05% | -11.7% |
| ASND | ASCENDIS PHARMAsponsored adr | $189,750,000 | -16.4% | 1,970,000 | 0.0% | 7.92% | +0.9% | |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $164,261,000 | -9.3% | 2,437,100 | +15.2% | 6.85% | +9.4% |
| AMRN | Buy | AMARIN CORP PLCsponsored adr | $129,163,000 | -11.2% | 8,520,000 | +13.6% | 5.39% | +7.2% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $126,387,000 | -40.6% | 1,678,000 | +19.9% | 5.27% | -28.3% |
| HZNP | HORIZON THERAPEUTICS PLC | $108,920,000 | +13.2% | 4,000,000 | 0.0% | 4.54% | +36.6% | |
| ARGX | Sell | ARGENX SEsponsored adr | $95,157,000 | -20.0% | 835,000 | -0.6% | 3.97% | -3.5% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $89,022,000 | -28.7% | 11,100,000 | +11.0% | 3.71% | -13.9% |
| MYOK | Buy | MYOKARDIA INC | $80,973,000 | +17.4% | 1,552,700 | +12.9% | 3.38% | +41.8% |
| ZGNX | Sell | ZOGENIX INC | $75,075,000 | -22.4% | 1,875,000 | -7.4% | 3.13% | -6.4% |
| ATNX | Buy | ATHENEX INC | $71,652,000 | -21.4% | 5,890,000 | +27.9% | 2.99% | -5.2% |
| TCDA | TRICIDA INC | $67,914,000 | -21.8% | 2,200,000 | 0.0% | 2.83% | -5.6% | |
| PCRX | Buy | PACIRA BIOSCIENCES INC | $60,912,000 | +250.1% | 1,600,000 | +300.0% | 2.54% | +322.8% |
| KPTI | New | KARYOPHARM THERAPEUTICS INC | $58,201,000 | – | 6,050,000 | +100.0% | 2.43% | – |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS INC | $48,520,000 | -2.9% | 1,000,000 | +5.3% | 2.02% | +17.2% |
| ACAD | Sell | ACADIA PHARMACEUTICALS INC | $31,941,000 | -9.8% | 887,500 | -33.0% | 1.33% | +8.8% |
| BDSI | BIODELIVERY SCIENCES INTL | $31,259,000 | -9.5% | 7,424,867 | 0.0% | 1.30% | +9.2% | |
| MDGL | MADRIGAL PHARMACEUTICALS INC | $31,039,000 | -17.7% | 360,000 | 0.0% | 1.30% | -0.7% | |
| ALLO | ALLOGENE THERAPEUTICS INC | $30,760,000 | +1.5% | 1,128,594 | 0.0% | 1.28% | +22.4% | |
| ADVM | Buy | ADVERUM BIOTECHNOLOGIES INC | $23,163,000 | -44.3% | 4,250,000 | +21.4% | 0.97% | -32.9% |
| PTCT | PTC THERAPEUTICS INC | $23,133,000 | -24.8% | 684,000 | 0.0% | 0.96% | -9.3% | |
| XENE | XENON PHARMACEUTICALS INC | $21,624,000 | -8.6% | 2,400,000 | 0.0% | 0.90% | +10.3% | |
| MDCO | Sell | MEDICINES CO | $18,581,000 | -44.9% | 371,623 | -59.8% | 0.78% | -33.5% |
| QURE | New | UNIQURE NV | $14,366,000 | – | 365,000 | +100.0% | 0.60% | – |
| CBAY | CYMABAY THERAPEUTICS INC | $13,824,000 | -28.5% | 2,700,000 | 0.0% | 0.58% | -13.6% | |
| KOD | Sell | KODIAK SCIENCES INC | $7,190,000 | +6.5% | 500,000 | -13.3% | 0.30% | +28.8% |
| FENC | FENNEC PHARMACEUTICALS INC | $5,320,000 | +20.3% | 1,105,999 | 0.0% | 0.22% | +45.1% | |
| TLGT | TELIGENT INC | $4,970,000 | +50.8% | 5,231,206 | 0.0% | 0.21% | +81.6% | |
| TPTX | New | TURNING POINT THERAPEUTICS INC | $3,760,000 | – | 100,000 | +100.0% | 0.16% | – |
| ALIM | ALIMERA SCIENCES INC | $3,534,000 | -36.4% | 6,240,000 | 0.0% | 0.15% | -23.4% | |
| RCKT | ROCKET PHARMACEUTICALS INC | $3,329,000 | -22.3% | 285,714 | 0.0% | 0.14% | -6.1% | |
| IWM | Exit | iShares Russell 2000put | $0 | – | -250,000 | -100.0% | -0.00% | – |
| Exit | INTEC PHARMA LTD | $0 | – | -820,000 | -100.0% | -0.12% | – | |
| SRPT | Exit | SAREPTA THERAPEUTICS INCcall | $0 | – | -250,000 | -100.0% | -0.19% | – |
| ADPT | Exit | ADAPTIVE BIOTECHNOLOGIES | $0 | – | -200,000 | -100.0% | -0.33% | – |
| ARRY | Exit | ARRAY BIOPHARMA INC | $0 | – | -2,000,000 | -100.0% | -3.20% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 36 | Q3 2023 | 17.9% |
| MIRATI THERAPEUTICS INC. | 35 | Q3 2023 | 17.2% |
| BIOMARIN PHARMACEUTICAL INC | 31 | Q3 2023 | 8.0% |
| SAREPTA THERAPUTICS INC | 28 | Q3 2023 | 14.8% |
| ASCENDIS PHARMA | 28 | Q3 2023 | 9.1% |
| ARGENX SE | 26 | Q3 2023 | 9.5% |
| IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
| FENNEC PHARMACEUTICALS INC | 25 | Q3 2023 | 0.4% |
| MADRIGAL PHARMACEUTICALS INC | 22 | Q3 2023 | 7.2% |
| XENON PHARMACEUTICALS INC | 22 | Q3 2023 | 3.3% |
View Avoro Capital Advisors LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adverum Biotechnologies, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| DICE Therapeutics, Inc. | February 14, 2023 | 2,525,555 | 5.3% |
| IOVANCE BIOTHERAPEUTICS, INC. | February 14, 2023 | 7,020,000 | 4.4% |
| IVERIC bio, Inc. | February 14, 2023 | 6,750,000 | 5.0% |
| Kura Oncology, Inc. | February 14, 2023 | 3,105,000 | 4.5% |
| Aadi Bioscience, Inc. | September 26, 2022 | 2,849,402 | 11.7% |
| ARENA PHARMACEUTICALS INC | February 11, 2022 | 1,235,000 | 2.0% |
| AVADEL PHARMACEUTICALS PLC | February 11, 2022 | 1,670,000 | 2.9% |
| FENNEC PHARMACEUTICALS INC. | February 11, 2022 | 1,200,000 | 4.6% |
| POINT Biopharma Global Inc.Sold out | February 11, 2022 | 0 | 0.0% |
View Avoro Capital Advisors LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-04-23 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Avoro Capital Advisors LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.